CVS Group’s (CVSG) Buy Rating Reiterated at Berenberg Bank

CVS Group (LON:CVSG)‘s stock had its “buy” rating reiterated by equities research analysts at Berenberg Bank in a research note issued to investors on Thursday,Digital Look reports. They presently have a GBX 2,000 price target on the stock. Berenberg Bank’s target price would suggest a potential upside of 58.98% from the stock’s previous close.

Separately, Jefferies Financial Group lowered CVS Group to a “hold” rating and cut their price target for the stock from GBX 1,420 to GBX 1,350 in a report on Thursday, July 9th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,710.

CVS Group Stock Performance

Shares of CVSG opened at GBX 1,258 on Thursday. The company has a debt-to-equity ratio of 92.34, a current ratio of 1.07 and a quick ratio of 0.90. The stock has a 50-day moving average of GBX 1,222.10 and a 200-day moving average of GBX 1,247.87. The company has a market cap of £870.54 million, a PE ratio of 18.26, a P/E/G ratio of 1.77 and a beta of 1.06. CVS Group has a one year low of GBX 1,062 and a one year high of GBX 1,648.

CVS Group declared that its board has authorized a stock buyback program on Tuesday, May 26th that allows the company to buyback 0 outstanding shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling at CVS Group

In other CVS Group news, insider Scott Morrison purchased 987 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The shares were acquired at an average price of GBX 1,270 per share, with a total value of £12,534.90. Company insiders own 1.43% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.